WILD-TYPE P53 DOWN-REGULATES TRANSCRIPTION FROM ONCOGENIC HUMAN PAPILLOMAVIRUS PROMOTERS THROUGH THE EPITHELIAL SPECIFIC ENHANCER

被引:0
|
作者
DESAINTES, C [1 ]
HALLEZ, S [1 ]
DETREMMERIE, O [1 ]
BURNY, A [1 ]
机构
[1] FREE UNIV BRUSSELS,CHIM BIOL LAB,B-1640 RHODE ST GENESE,BELGIUM
关键词
HPV; P53; TBP; TRANSCRIPTION; EPITHELIAL ENHANCER;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High-risk Human Papillomavirus (HPV) E6 and E7 immortalizing oncoproteins are expressed from promoter tightly regulated by an epithelial specific enhancer. To determine if the p53 tumour suppressor protein can modulate the transcription of these genes, we performed co-transfection experiments with plasmids containing the HPV type 16 or 18 long control regions linked to the chloramphenicol acetyl transferase gene, along with p53 expression vectors. Wild-type, but not mutant, murine or human p53 expression vectors reduced the activity of reporter constructs when co-transfected into HeLa or C33 cell lines. Mutations within the HPV TATA boxes did not significantly alter the levels of p53 repression, suggesting a TATA-independent mechanism. Deletion analyses mapped the p53-responsive domain to the constitutive 230 base pair epithelial specific enhancer. In addition, the enhancer could confer p53-mediated repression when placed upstream of a heterologous promoter.
引用
收藏
页码:2155 / 2161
页数:7
相关论文
共 50 条
  • [41] TRANSCRIPTIONAL REPRESSION IN NORMAL HUMAN KERATINOCYTES BY WILD-TYPE AND MUTANT P53
    ALVAREZSALAS, LM
    VELAZQUEZ, A
    LOPEZBAYGHEN, E
    WOODWORTH, CD
    GARRIDO, E
    GARIGLIO, P
    DIPAOLO, JA
    CANCER LETTERS, 1995, 91 (01) : 85 - 92
  • [42] HUMAN GLIOMAS WITH WILD-TYPE P53 EXPRESS BCL-2
    ALDERSON, LM
    CASTLEBERG, RL
    HARSH, GR
    LOUIS, DN
    HENSON, JW
    CANCER RESEARCH, 1995, 55 (05) : 999 - 1001
  • [43] Transduction of a wild-type p53 gene into human malignant melanoma cells
    Hakim, AA
    CANCER GENE THERAPY, 2001, 8 : S8 - S8
  • [44] Nuclear exclusion of wild-type p53 in immortalized human retinoblastoma cells
    Schlamp, CL
    Poulsen, GL
    Nork, TM
    Nickells, RW
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (20) : 1530 - 1536
  • [45] Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53
    Lisa S St. John
    Edward R Sauter
    Meenhard Herlyn
    Samuel Litwin
    Karen Adler-Storthz
    Cancer Gene Therapy, 2000, 7 : 749 - 756
  • [46] Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein
    A Vinyals
    M A Peinado
    M Gonzalez-Garrigues
    M Monzó
    R D Bonfil
    A Fabra
    Gene Therapy, 1999, 6 : 22 - 33
  • [47] Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein
    Vinyals, A
    Peinado, MA
    Gonzalez-Garrigues, M
    Monzó, M
    Bonfil, RD
    Fabra, A
    GENE THERAPY, 1999, 6 (01) : 22 - 33
  • [48] Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53
    Sugrue, MM
    Shin, DY
    Lee, SW
    Aaronson, SA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (18) : 9648 - 9653
  • [49] Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53
    John, LSS
    Sauter, ER
    Herlyn, M
    Litwin, S
    Adler-Storthz, K
    CANCER GENE THERAPY, 2000, 7 (05) : 749 - 756
  • [50] Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts
    Watanabe, T
    Sullenger, BA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (15) : 8490 - 8494